Parathyroid hormone (PTH) is your body’s primary tool for keeping blood calcium levels stable. It works by acting on three organs simultaneously: bones, kidneys, and (indirectly) the intestines. When blood calcium drops even slightly, PTH is released from four tiny glands behind your thyroid, triggering a coordinated response that pulls calcium back into the bloodstream. Normal PTH levels in a healthy adult range from 10 to 65 pg/mL.
How the Parathyroid Glands Know When to Act
Your parathyroid glands contain a protein called the calcium-sensing receptor, or CaSR. This receptor sits on the surface of parathyroid cells and constantly monitors the amount of calcium floating in your blood. When calcium levels are adequate, calcium molecules bind to CaSR, which shuts down PTH production. The receptor also limits the growth of parathyroid cells themselves, keeping the glands small and appropriately sized.
When blood calcium dips, fewer calcium molecules bind to CaSR, and that brake is released. The parathyroid glands respond within seconds, dumping stored PTH into the bloodstream. This creates a tight feedback loop: PTH raises calcium, higher calcium silences PTH, and the cycle repeats continuously throughout the day.
What PTH Does to Bone
PTH’s effect on bone is its most complex action, and it works indirectly. PTH doesn’t talk to the cells that break down bone (osteoclasts) directly. Instead, it signals to bone-building cells called osteoblasts and, more importantly, to osteocytes, the long-lived cells embedded deep within bone tissue. When PTH reaches these cells, it ramps up their production of a signaling molecule called RANKL while simultaneously dialing down a protective molecule called OPG. RANKL is what activates osteoclasts, the cells that dissolve small amounts of bone and release the stored calcium and phosphate into the bloodstream.
Osteocytes appear to be the more important target. Research in endocrinology has shown that PTH increases RANKL production about 12-fold in osteocytes compared to roughly 9-fold in osteoblasts. In animal models where PTH receptor signaling was permanently switched on in osteocytes, the result was dramatically elevated bone breakdown: more osteoclasts, higher resorption markers in the blood, and increased porosity in cortical bone (the dense outer shell).
This might sound destructive, but it’s actually a survival mechanism. Your skeleton serves as a massive calcium reservoir, and PTH taps into it when dietary calcium is insufficient. Problems only arise when PTH stays elevated for prolonged periods, which leads to progressive bone loss.
How PTH Handles Calcium in the Kidneys
Your kidneys filter roughly 180 liters of fluid per day, and a significant amount of calcium passes through that filter. Without PTH, more of that calcium would be lost in urine. PTH acts on the distal convoluted tubule, a specific segment deep in the kidney’s filtering system, to reclaim calcium before it leaves the body.
The mechanism is precise. PTH activates a sodium-calcium exchanger located exclusively in the distal tubule. This exchanger sits on the back side of the tubule cells (the side facing blood vessels) and uses the natural sodium gradient to pull calcium out of the urine-forming fluid and shuttle it back into the bloodstream. PTH doesn’t affect calcium transport in other parts of the kidney’s filtering system, only in this one segment where the right molecular machinery exists.
Interestingly, CaSR plays a role in the kidneys too. When blood calcium is already high, calcium binds to CaSR on kidney cells and blocks calcium reabsorption, allowing excess calcium to leave through urine. This provides another layer of protection against dangerously high calcium levels.
How PTH Flushes Phosphate
While PTH conserves calcium in the kidneys, it does the opposite with phosphate. This is important because calcium and phosphate have an inverse relationship in the blood. If both rose at the same time (as they would from bone breakdown), they’d bind together and form deposits in soft tissues. PTH prevents this by forcing the kidneys to excrete phosphate.
Phosphate is normally reabsorbed in the proximal tubule, an earlier segment of the kidney’s filtering system, through sodium-dependent transport proteins. The dominant one handles about 80% of phosphate reabsorption. PTH triggers a chain of events that physically removes these transporters from the cell surface. Within minutes, the main transporter is pulled inward through a process called endocytosis and sent to be broken down. A secondary transporter is removed too, though this takes hours rather than minutes.
The result is straightforward: with fewer transporters on the surface, less phosphate gets reclaimed, and more spills into the urine. This keeps blood phosphate from climbing even as PTH liberates phosphate from bone.
PTH’s Role in Vitamin D Activation
PTH has a third, slower strategy for raising blood calcium: boosting the production of the active form of vitamin D. The vitamin D you get from sunlight or supplements is inactive. It first passes through the liver for a partial conversion, then must travel to the kidneys for the final activation step. PTH stimulates the kidney enzyme responsible for that final step, converting the circulating form of vitamin D into calcitriol, the fully active hormone.
Calcitriol then travels to the intestines, where it increases calcium absorption from food. This is the only way PTH influences intestinal calcium uptake, and it’s an indirect one. The process takes longer than PTH’s direct effects on bone and kidneys, but it’s the most sustainable source of calcium because it pulls from your diet rather than your skeleton.
What Happens at the Cellular Level
PTH exerts all of these effects by binding to a receptor called PTH1R, found on the surface of target cells in bone and kidney. Once PTH locks onto this receptor, it triggers an internal signaling cascade. The primary pathway involves a molecule called cyclic AMP (cAMP), which acts as a messenger inside the cell, activating enzymes that carry out PTH’s instructions. The receptor can also activate secondary pathways that release calcium stored inside cells and influence cell growth and survival.
This same receptor is shared by a related molecule called PTH-related protein, or PTHrP. Despite the similar name and shared receptor, PTHrP behaves very differently. PTH is a classical hormone released from one location (the parathyroid glands) into the bloodstream to act on distant organs. PTHrP, by contrast, is produced by many different tissues and acts locally, influencing nearby cells rather than traveling through the blood. PTHrP plays roles in the cardiovascular system and in fetal development, but it’s also the molecule responsible for dangerously high calcium levels in certain cancers.
When PTH Levels Go Wrong
In primary hyperparathyroidism, one or more parathyroid glands become overactive, usually due to a benign tumor. The hallmark is high blood calcium paired with a PTH level that is either elevated or “inappropriately normal,” meaning the body should have suppressed PTH in response to high calcium but failed to do so. Over time, the constant PTH excess pulls calcium from bones, raises kidney stone risk, and can cause fatigue, muscle weakness, and cognitive fog.
Hypoparathyroidism is the opposite problem. PTH production drops to very low or undetectable levels, most commonly after thyroid or parathyroid surgery. Without PTH, blood calcium falls, phosphate rises (because the kidneys stop excreting it), and active vitamin D production drops. The resulting low calcium causes numbness, tingling, muscle cramps, and in severe cases, seizures. Lab work typically shows low calcium, high phosphate, and PTH levels below what standard assays can detect.